IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $886,000 | -14.6% | 92,500 | -1.6% | 0.36% | -11.9% |
| Q2 2022 | $1,038,000 | -34.0% | 94,000 | -0.5% | 0.41% | -24.2% |
| Q1 2022 | $1,573,000 | -12.8% | 94,500 | 0.0% | 0.54% | +1.3% |
| Q4 2021 | $1,804,000 | -22.6% | 94,500 | 0.0% | 0.54% | -23.4% |
| Q3 2021 | $2,330,000 | -8.1% | 94,500 | -3.0% | 0.70% | -18.8% |
| Q2 2021 | $2,535,000 | +10.9% | 97,444 | +35.0% | 0.86% | +32.9% |
| Q1 2021 | $2,285,000 | -28.8% | 72,168 | +4.3% | 0.65% | -27.1% |
| Q4 2020 | $3,209,000 | +729.2% | 69,168 | +488.7% | 0.89% | +616.1% |
| Q3 2020 | $387,000 | +779.5% | 11,750 | +135.0% | 0.12% | +726.7% |
| Q4 2018 | $44,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |